LeonaBio, Inc. (LONA)
6.34
-0.45
(-6.63%)
USD |
NASDAQ |
Sep 21, 16:00
6.34
0.00 (0.00%)
After-Hours: 20:00
LeonaBio Shareholders Equity (Quarterly) : 33.60M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.60M |
| March 31, 2026 | 49.30M |
| December 31, 2025 | 27.79M |
| September 30, 2025 | 26.79M |
| June 30, 2025 | 31.99M |
| March 31, 2025 | 37.33M |
| December 31, 2024 | 44.84M |
| September 30, 2024 | 57.58M |
| June 30, 2024 | 83.34M |
| March 31, 2024 | 106.74M |
| December 31, 2023 | 130.19M |
| September 30, 2023 | 154.76M |
| June 30, 2023 | 184.98M |
| March 31, 2023 | 211.12M |
| Date | Value |
|---|---|
| December 31, 2022 | 235.14M |
| September 30, 2022 | 262.25M |
| June 30, 2022 | 280.56M |
| March 31, 2022 | 301.98M |
| December 31, 2021 | 321.08M |
| September 30, 2021 | 336.24M |
| June 30, 2021 | 350.71M |
| March 31, 2021 | 363.22M |
| December 31, 2020 | 274.28M |
| September 30, 2020 | 259.47M |
| June 30, 2020 | 80.01M |
| March 31, 2020 | |
| December 31, 2019 | -2.672M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.89M |
| Total Liabilities (Quarterly) | 23.30M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 7.011 |
| Net Debt Paydown Yield | 0.12% |